Stryker reports continued growth in Q2 2012

Stryker has reported its operating results for the second quarter of 2012, during which it experienced growth in terms of sales and earnings.

Figures from the medical technology company's financial report showed that its net sales came to $2.1 billion (1.34 billion pounds), up by 2.9 percent year over year, while adjusted diluted net earnings per share grew by almost nine percent to $0.98.

Improved sales were recorded across the company's reconstructive, MedSurg and neurotechnology and spine divisions, while 0.7 million shares were repurchased at a cost of $39 million.

Curt Hartman, interim chief executive officer, vice-president and chief financial officer of Stryker, said: "We remain on track to deliver on our financial commitments for 2012, which include two to five percent growth excluding the impact of acquisitions and currency and double-digit adjusted per share earnings growth."

Earlier this year, the firm helped to co-found the Environmentally Preferable Purchasing Business Leadership Coalition, a group of healthcare suppliers dedicated to green procurement.